数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Paul Hobaica 男 Independent Director 61 未披露 0.60 2026-02-10
Daniel Hall 男 Independent Director 53 未披露 1.18 2026-02-10
Chris G. Pulos 男 Independent Director 64 未披露 未持股 2026-02-10
Robert Gasparini 男 Independent Director 70 未披露 2.90 2026-02-10
Heather Monahan 女 Independent Director 51 未披露 1.18 2026-02-10
George O Leary 男 Director 63 未披露 3.91 2026-02-10
Michael Dent 男 Chairman of the Board and Chief Executive Officer 61 3.50万美元 259.61 2026-02-10
Jason Bishara 男 Independent Director 52 未披露 0.83 2026-02-10

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Duncan McGillivray 男 Chief Operating Officer 65 26.27万美元 2.00 2026-02-10
Michael Dent 男 Chairman of the Board and Chief Executive Officer 61 3.50万美元 259.61 2026-02-10
Jeremy Daniel 男 Chief Financial Officer 49 5.23万美元 未持股 2026-02-10

董事简历

中英对照 |  中文 |  英文
Paul Hobaica

Paul Hobaica是一位成就卓著的董事会认证医生,在医疗领域拥有超过25年的经验。桥水州立大学BIES行政管理专业毕业。Hobaica博士是马萨诸塞州本地人,1996年至1999年在马萨诸塞州大学医学中心的工作人员中任职,之后于1999年搬到佛罗里达州。在佛罗里达州,霍拜卡医生最初加入那不勒斯社区医院的急诊科工作了一年,之后开始了自己的社区实践。他还曾作为一名消防员和紧急医疗技术员工作了几年,专门针对科利尔县急救人员的需求开发了唯一的医疗保健项目,在那里他仍然担任北科利尔消防救援和伊莫卡莱消防救援的地区医师。Hobaica博士于2011年春季加入Arthur,Inc.,目前担任公司医疗总监,为公司的医疗和llness项目提供战略领导和指导。


Paul Hobaica is a highly accomplished board certified physician with over 25 years of experience in the medical field. He is a graduate of Bridgewater State University with a degree in biness administration. A Massachetts native, Dr. Hobaica served on the staff at the University of Massachetts Medical Center from 1996 through 1999 before relocating to Florida in 1999. In Florida, Dr. Hobaica initially joined the emergency department at Naples Community Hospital for a year before starting his own community practice. He also worked as a firefighter and emergency medical technician for several years and developed the only healthcare program specific for the needs of the first responders of Collier County, where he still serves as the District Physician for North Collier Fire Rescue and Immokalee Fire Rescue. Dr. Hobaica joined Arthrex, Inc., in the spring of 2011, where is currently the Corporate Medical Director, providing strategic leadership and direction to the Company's medical and llness programs.
Paul Hobaica是一位成就卓著的董事会认证医生,在医疗领域拥有超过25年的经验。桥水州立大学BIES行政管理专业毕业。Hobaica博士是马萨诸塞州本地人,1996年至1999年在马萨诸塞州大学医学中心的工作人员中任职,之后于1999年搬到佛罗里达州。在佛罗里达州,霍拜卡医生最初加入那不勒斯社区医院的急诊科工作了一年,之后开始了自己的社区实践。他还曾作为一名消防员和紧急医疗技术员工作了几年,专门针对科利尔县急救人员的需求开发了唯一的医疗保健项目,在那里他仍然担任北科利尔消防救援和伊莫卡莱消防救援的地区医师。Hobaica博士于2011年春季加入Arthur,Inc.,目前担任公司医疗总监,为公司的医疗和llness项目提供战略领导和指导。
Paul Hobaica is a highly accomplished board certified physician with over 25 years of experience in the medical field. He is a graduate of Bridgewater State University with a degree in biness administration. A Massachetts native, Dr. Hobaica served on the staff at the University of Massachetts Medical Center from 1996 through 1999 before relocating to Florida in 1999. In Florida, Dr. Hobaica initially joined the emergency department at Naples Community Hospital for a year before starting his own community practice. He also worked as a firefighter and emergency medical technician for several years and developed the only healthcare program specific for the needs of the first responders of Collier County, where he still serves as the District Physician for North Collier Fire Rescue and Immokalee Fire Rescue. Dr. Hobaica joined Arthrex, Inc., in the spring of 2011, where is currently the Corporate Medical Director, providing strategic leadership and direction to the Company's medical and llness programs.
Daniel Hall

丹尼尔·霍尔的职业生涯始于为康尼格拉的一家全资子公司提供各种各样的会计服务。1995年,霍尔开始为世界领先的骨科手术器械设计、研究、制造和医学教育公司Arthur,Inc.工作时,他转型进入医疗器械行业。他担任过多个职务,责任越来越大,他目前担任股东关系和税务副总裁,负责全球企业的财务、投资、财务审计、税务战略/合规和公司结构活动。除了在Arthur任职外,霍尔先生还是Krisdan Management,Inc.单一家族办公室的副总裁。以这种身份,他负责超高净值税收规划、战略和合规,以及TRT和遗产规划、投资监督、慈善事业和财务报告。霍尔先生在北达科他州立大学获得BINCE行政和会计学学士学位。霍尔先生还是佛罗里达州注册会计师,也是美国注册会计师协会(AICPA)和佛罗里达州注册会计师协会(FICPA)的成员。


Daniel Hall began his career performing a wide variety of accounting services for a wholly owned subsidiary of ConAgra. In 1995, Mr. Hall transitioned into the medical device indtry when he began working for Arthrex, Inc., a world leader in orthopedic surgical device design, research, manufacturing and medical education. He has held vario positions of increasing responsibility culminating in his current role as Vice President of Shareholder Relations and Taxation, where he is responsible for the global enterprise's treasury, investment, financial audit, tax strategy/compliance, and corporate structuring activities. In addition to his role with Arthrex, Mr. Hall is also Vice President of Krisdan Management, Inc. a Single Family Office. In this capacity, he is responsible for ultra high net worth tax planning, strategy and compliance, as ll as trt and estate planning, investment oversight, philanthropy and financial reporting. Mr. Hall earned a BS in Biness Administration and Accounting from North Dakota State University. Mr. Hall is also Florida registered Certified Public Accountant and a member of both the American Institute of Certified Public Accountants (AICPA) and the Florida Institute of Certified Public Accountants (FICPA).
丹尼尔·霍尔的职业生涯始于为康尼格拉的一家全资子公司提供各种各样的会计服务。1995年,霍尔开始为世界领先的骨科手术器械设计、研究、制造和医学教育公司Arthur,Inc.工作时,他转型进入医疗器械行业。他担任过多个职务,责任越来越大,他目前担任股东关系和税务副总裁,负责全球企业的财务、投资、财务审计、税务战略/合规和公司结构活动。除了在Arthur任职外,霍尔先生还是Krisdan Management,Inc.单一家族办公室的副总裁。以这种身份,他负责超高净值税收规划、战略和合规,以及TRT和遗产规划、投资监督、慈善事业和财务报告。霍尔先生在北达科他州立大学获得BINCE行政和会计学学士学位。霍尔先生还是佛罗里达州注册会计师,也是美国注册会计师协会(AICPA)和佛罗里达州注册会计师协会(FICPA)的成员。
Daniel Hall began his career performing a wide variety of accounting services for a wholly owned subsidiary of ConAgra. In 1995, Mr. Hall transitioned into the medical device indtry when he began working for Arthrex, Inc., a world leader in orthopedic surgical device design, research, manufacturing and medical education. He has held vario positions of increasing responsibility culminating in his current role as Vice President of Shareholder Relations and Taxation, where he is responsible for the global enterprise's treasury, investment, financial audit, tax strategy/compliance, and corporate structuring activities. In addition to his role with Arthrex, Mr. Hall is also Vice President of Krisdan Management, Inc. a Single Family Office. In this capacity, he is responsible for ultra high net worth tax planning, strategy and compliance, as ll as trt and estate planning, investment oversight, philanthropy and financial reporting. Mr. Hall earned a BS in Biness Administration and Accounting from North Dakota State University. Mr. Hall is also Florida registered Certified Public Accountant and a member of both the American Institute of Certified Public Accountants (AICPA) and the Florida Institute of Certified Public Accountants (FICPA).
Chris G. Pulos

Chris G. Pulos曾担任Marsh & McLennan中部地区高级副总裁,就具有成本效益、以会员为中心的福利平台为不同行业的雇主提供建议。普洛斯先生对驱动医疗保健和保险转型的市场动态有着深刻的理解。他在围绕基于价值的结果调整利益相关者方面的背景直接支持了公司的战略,即提供更好的访问、降低成本和大规模的协调护理。他的职业生涯建立在建立牢固的伙伴关系、促进创新和推进有利于提供者和他们所服务的人群的解决方案上。他曾担任迈阿密山谷医院基金会的董事会成员,帮助管理超过7000万美元的资产,并在最后两年担任董事长。他目前在诺斯蒙特市学校董事会任职,影响了近5000名学生,并在包括当地奥杜邦协会在内的多个非营利委员会任职。


Chris G. Pulos has served as Senior Vice President for Marsh & McLennan in the Midst Region, advising employers across diverse indtries on cost effective, member centric benefit platforms. Mr. Pulos has a deep understanding of the market dynamics driving healthcare and insurance transformation. His background in aligning stakeholders around value based outcomes directly supports the Company's strategy to deliver improved access, reduced costs, and coordinated care at scale. He has built a career on forging strong partnerships, fostering innovation, and advancing solutions that benefit both providers and the populations they serve. He served on the board of the Miami Valley Hospital Foundation, helping manage more than $70 million in assets and acting as Chairman during his final two years. He currently serves on the Northmont City School Board, impacting nearly 5,000 students, and has held roles on multiple nonprofit boards including the local Audubon Society.
Chris G. Pulos曾担任Marsh & McLennan中部地区高级副总裁,就具有成本效益、以会员为中心的福利平台为不同行业的雇主提供建议。普洛斯先生对驱动医疗保健和保险转型的市场动态有着深刻的理解。他在围绕基于价值的结果调整利益相关者方面的背景直接支持了公司的战略,即提供更好的访问、降低成本和大规模的协调护理。他的职业生涯建立在建立牢固的伙伴关系、促进创新和推进有利于提供者和他们所服务的人群的解决方案上。他曾担任迈阿密山谷医院基金会的董事会成员,帮助管理超过7000万美元的资产,并在最后两年担任董事长。他目前在诺斯蒙特市学校董事会任职,影响了近5000名学生,并在包括当地奥杜邦协会在内的多个非营利委员会任职。
Chris G. Pulos has served as Senior Vice President for Marsh & McLennan in the Midst Region, advising employers across diverse indtries on cost effective, member centric benefit platforms. Mr. Pulos has a deep understanding of the market dynamics driving healthcare and insurance transformation. His background in aligning stakeholders around value based outcomes directly supports the Company's strategy to deliver improved access, reduced costs, and coordinated care at scale. He has built a career on forging strong partnerships, fostering innovation, and advancing solutions that benefit both providers and the populations they serve. He served on the board of the Miami Valley Hospital Foundation, helping manage more than $70 million in assets and acting as Chairman during his final two years. He currently serves on the Northmont City School Board, impacting nearly 5,000 students, and has held roles on multiple nonprofit boards including the local Audubon Society.
Robert Gasparini

罗伯特·加斯帕里尼的职业生涯始于CT大学的遗传学实验室,并于1985年至1990年成为那里的助理教授。从1990年到1993年,他在塔夫茨大学担任遗传学技术主任,从1993年到1997年,他担任马萨诸塞州列克星敦产前诊断中心(一家大众综合附属机构)的助理主任。Gasparini先生还曾在1998年至2000年期间担任Ventana Medical Systems的全球和战略营销经理,并于2001年成为加州尔湾实验室的遗传学总监。Gasparini先生是NeoGenomics Laboratories的关键高管,曾在公司担任多项职务,包括总裁和首席科学官,自2004年至2014年担任董事会成员。加斯帕里尼先生在国家委员会和董事会服务了28年,发表了15篇同行评论文章和30多篇同行评论摘要。


Robert Gasparini started his career in the genetics laboratories at the University of CT and became an assistant professor there from 1985 1990. From 1990 1993 he was Technical Director of Genetics at Tufts and from 1993 1997 he was Assistant Director for the Prenatal Diagnostic Center in Lexington MA (a Mass General affiliate). Mr. Gasparini also worked as a Manager of Worldwide and Strategic Marketing with Ventana Medical Systems from 1998 2000 and in 2001, he became Director of Genetics for Labs in Irvine California. Mr. Gasparini was a key executive at NeoGenomics Laboratories serving in many capacities with the company including President and Chief Scientific Officer as ll as being on the Board of Directors from 2004 2014. Mr. Gasparini has 28 years of combined service on national committees and boards of directors and has published 15 peer revied articles and over 30 peer revied abstracts.
罗伯特·加斯帕里尼的职业生涯始于CT大学的遗传学实验室,并于1985年至1990年成为那里的助理教授。从1990年到1993年,他在塔夫茨大学担任遗传学技术主任,从1993年到1997年,他担任马萨诸塞州列克星敦产前诊断中心(一家大众综合附属机构)的助理主任。Gasparini先生还曾在1998年至2000年期间担任Ventana Medical Systems的全球和战略营销经理,并于2001年成为加州尔湾实验室的遗传学总监。Gasparini先生是NeoGenomics Laboratories的关键高管,曾在公司担任多项职务,包括总裁和首席科学官,自2004年至2014年担任董事会成员。加斯帕里尼先生在国家委员会和董事会服务了28年,发表了15篇同行评论文章和30多篇同行评论摘要。
Robert Gasparini started his career in the genetics laboratories at the University of CT and became an assistant professor there from 1985 1990. From 1990 1993 he was Technical Director of Genetics at Tufts and from 1993 1997 he was Assistant Director for the Prenatal Diagnostic Center in Lexington MA (a Mass General affiliate). Mr. Gasparini also worked as a Manager of Worldwide and Strategic Marketing with Ventana Medical Systems from 1998 2000 and in 2001, he became Director of Genetics for Labs in Irvine California. Mr. Gasparini was a key executive at NeoGenomics Laboratories serving in many capacities with the company including President and Chief Scientific Officer as ll as being on the Board of Directors from 2004 2014. Mr. Gasparini has 28 years of combined service on national committees and boards of directors and has published 15 peer revied articles and over 30 peer revied abstracts.
Heather Monahan

Heather Monahan是畅销书作家、主讲人、Ted X主讲人、执行教练和Boss in Heels创始人。莫纳汉女士是玻璃天花板奖得主,被评为2017年电台最具影响力的女性之一,并于2018年被Thrive Global选为突破极限的女性创始人。她的书《Confidence Creator》在亚马逊的Biness Biographies上排名第一,Biness Motivation列出了它首次亮相的首个ek。她的播客《创造信心》(Creating Confidence)以值得注意的名人和企业家为主角,首次登上了苹果播客排行榜前200名。莫纳汉女士被真正的领导人评为2020年前40位女性主旨发言人之一。她的Ted X演讲被提升到TED,并被翻译成6种语言。哈珀·柯林斯领导力于2021年出版了她的著作《战胜Y恶棍:掌握Y信念、行动和知识以战胜任何逆境》。莫纳汉女士曾在今日美国有线电视新闻网、《福布斯》、《快公司》和史蒂夫·哈维秀上亮相,最近还被任命为哈佛大学的客座教授。


Heather Monahan is a best selling author, keynote speaker, Ted X speaker, Executive Coach and founder of Boss In Heels. Ms. Monahan is a Glass Ceiling Award winner, was named one of the most Influential Women in Radio in 2017 and was selected as a Limit Breaking Female Founder by Thrive Global in 2018. Her book "Confidence Creator" was #1 on Amazon's Biness Biographies and Biness Motivation lists the first ek it debuted. Her podcast, Creating Confidence, which features noteworthy celebrities and entrepreneurs, debuted on the Top 200 Apple podcasts. Ms. Monahan was named one of the Top 40 Female Keynote Speakers for 2020 by Real Leaders. Her Ted X talk was promoted to TED and translated into 6 languages. Harper Collins Leadership published her book, Overcome Y Villains: Mastering Y Beliefs, Actions, and Knowledge to Conquer Any Adversity, in 2021. Ms. Monahan has been featured in A Today, CNN, Forbes, Fast Company and The Steve Harvey Show, and recently was named a Guest Professor at Harvard.
Heather Monahan是畅销书作家、主讲人、Ted X主讲人、执行教练和Boss in Heels创始人。莫纳汉女士是玻璃天花板奖得主,被评为2017年电台最具影响力的女性之一,并于2018年被Thrive Global选为突破极限的女性创始人。她的书《Confidence Creator》在亚马逊的Biness Biographies上排名第一,Biness Motivation列出了它首次亮相的首个ek。她的播客《创造信心》(Creating Confidence)以值得注意的名人和企业家为主角,首次登上了苹果播客排行榜前200名。莫纳汉女士被真正的领导人评为2020年前40位女性主旨发言人之一。她的Ted X演讲被提升到TED,并被翻译成6种语言。哈珀·柯林斯领导力于2021年出版了她的著作《战胜Y恶棍:掌握Y信念、行动和知识以战胜任何逆境》。莫纳汉女士曾在今日美国有线电视新闻网、《福布斯》、《快公司》和史蒂夫·哈维秀上亮相,最近还被任命为哈佛大学的客座教授。
Heather Monahan is a best selling author, keynote speaker, Ted X speaker, Executive Coach and founder of Boss In Heels. Ms. Monahan is a Glass Ceiling Award winner, was named one of the most Influential Women in Radio in 2017 and was selected as a Limit Breaking Female Founder by Thrive Global in 2018. Her book "Confidence Creator" was #1 on Amazon's Biness Biographies and Biness Motivation lists the first ek it debuted. Her podcast, Creating Confidence, which features noteworthy celebrities and entrepreneurs, debuted on the Top 200 Apple podcasts. Ms. Monahan was named one of the Top 40 Female Keynote Speakers for 2020 by Real Leaders. Her Ted X talk was promoted to TED and translated into 6 languages. Harper Collins Leadership published her book, Overcome Y Villains: Mastering Y Beliefs, Actions, and Knowledge to Conquer Any Adversity, in 2021. Ms. Monahan has been featured in A Today, CNN, Forbes, Fast Company and The Steve Harvey Show, and recently was named a Guest Professor at Harvard.
George O Leary

自2014年1月起,George O Leary还担任InLight Capital Partners LLC的联合创始人和董事总经理。他是一位受过财务培训的高级管理人员,专门从事跨职能和内部边界的创新战略问题解决。O'Leary先生自2016年1月起担任私人营销自动化公司Referrizer,LLC的副董事长。O'Leary先生在2014年3月至2021年1月期间担任Timios Holdings Corp.董事会副主席。从2009年6月到2013年5月,O'Leary先生担任Protection PL Securities Corporation的董事长兼首席财务官,直到该公司被出售给Universal Protection Services。从2007年2月至2015年6月,O'Leary先生是NeoMedia Technologies的董事会成员。O'Leary先生自2006年6月起担任South Florida Corp.(“SKS”)SKS Consulting的创始人和总裁,在那里他与上市公司和私营公司合作,担任董事会代表和/或根据提供高管级管理专业知识的咨询协议,以及帮助实施和执行其公司的战略和运营计划。O'Leary先生创办SKS的使命是帮助公司就高增长计划和核心BINCE的执行进行FOC,同时剥离非核心BINCE资产。从1996年到2000年,O'Leary先生担任Communication ResCes Incorporated(“CRI”)的首席执行官兼总裁,在他任职期间,该公司的年收入从500万美元增长到4000万美元。在加入CRI之前,O'Leary先生是Cablevision Indtries的运营副总裁,在那里他经营着1.25亿美元的BINES,直到它被卖给了时代华纳。O'Leary先生的职业生涯始于Peat Marwick and Mitchell(毕马威)的高级会计师。O'Leary先生拥有锡耶纳学院以优异成绩获得的会计学学士学位。


George O Leary is also Co Founder and Managing Director of InLight Capital Partners LLC since January 2014. He is a financially trained senior executive specializing in innovative strategic problem solving across functional and indtry boundaries. Mr. O'Leary is Vice Chairman of Referrizer, LLC, a private marketing automation company, since January 2016. Mr. O'Leary was the Vice Chairman of the board of directors of Timios Holdings Corp. from March 2014 through January 2021. From June 2009 to May 2013 Mr. O'Leary was Chairman of the Board and Chief Financial Officer of Protection Pl Securities Corporation until it was sold to Universal Protection Services. From February 2007 to June 2015, Mr. O'Leary was a member of the Board of Directors of NeoMedia Technologies. Mr. O'Leary is founder and President of SKS Consulting of South Florida Corp. ("SKS") since June 2006 where he works with public and private companies in board representation and/or under consulting agreements providing executive level management expertise, as ll as helping the implementation and execution of their companies' strategic & operational plans. Mr. O'Leary started SKS with the mission to help companies foc on high growth initiatives and execution of their core biness while shedding non core biness assets. From 1996 to 2000, Mr. O'Leary was Chief Executive Officer and President of Communication Resces Incorporated ("CRI"), where annual revenues grew from $5 million to $40 million during his tenure. Prior to CRI, Mr. O'Leary was Vice President of Operations of Cablevision Indtries, where he ran $125 million of biness until it was sold to Time Warner. Mr. O'Leary started his professional career as a senior accountant with Peat Marwick and Mitchell (KPMG). Mr. O'Leary holds a B.B.A. degree in Accounting with honors from Siena College.
自2014年1月起,George O Leary还担任InLight Capital Partners LLC的联合创始人和董事总经理。他是一位受过财务培训的高级管理人员,专门从事跨职能和内部边界的创新战略问题解决。O'Leary先生自2016年1月起担任私人营销自动化公司Referrizer,LLC的副董事长。O'Leary先生在2014年3月至2021年1月期间担任Timios Holdings Corp.董事会副主席。从2009年6月到2013年5月,O'Leary先生担任Protection PL Securities Corporation的董事长兼首席财务官,直到该公司被出售给Universal Protection Services。从2007年2月至2015年6月,O'Leary先生是NeoMedia Technologies的董事会成员。O'Leary先生自2006年6月起担任South Florida Corp.(“SKS”)SKS Consulting的创始人和总裁,在那里他与上市公司和私营公司合作,担任董事会代表和/或根据提供高管级管理专业知识的咨询协议,以及帮助实施和执行其公司的战略和运营计划。O'Leary先生创办SKS的使命是帮助公司就高增长计划和核心BINCE的执行进行FOC,同时剥离非核心BINCE资产。从1996年到2000年,O'Leary先生担任Communication ResCes Incorporated(“CRI”)的首席执行官兼总裁,在他任职期间,该公司的年收入从500万美元增长到4000万美元。在加入CRI之前,O'Leary先生是Cablevision Indtries的运营副总裁,在那里他经营着1.25亿美元的BINES,直到它被卖给了时代华纳。O'Leary先生的职业生涯始于Peat Marwick and Mitchell(毕马威)的高级会计师。O'Leary先生拥有锡耶纳学院以优异成绩获得的会计学学士学位。
George O Leary is also Co Founder and Managing Director of InLight Capital Partners LLC since January 2014. He is a financially trained senior executive specializing in innovative strategic problem solving across functional and indtry boundaries. Mr. O'Leary is Vice Chairman of Referrizer, LLC, a private marketing automation company, since January 2016. Mr. O'Leary was the Vice Chairman of the board of directors of Timios Holdings Corp. from March 2014 through January 2021. From June 2009 to May 2013 Mr. O'Leary was Chairman of the Board and Chief Financial Officer of Protection Pl Securities Corporation until it was sold to Universal Protection Services. From February 2007 to June 2015, Mr. O'Leary was a member of the Board of Directors of NeoMedia Technologies. Mr. O'Leary is founder and President of SKS Consulting of South Florida Corp. ("SKS") since June 2006 where he works with public and private companies in board representation and/or under consulting agreements providing executive level management expertise, as ll as helping the implementation and execution of their companies' strategic & operational plans. Mr. O'Leary started SKS with the mission to help companies foc on high growth initiatives and execution of their core biness while shedding non core biness assets. From 1996 to 2000, Mr. O'Leary was Chief Executive Officer and President of Communication Resces Incorporated ("CRI"), where annual revenues grew from $5 million to $40 million during his tenure. Prior to CRI, Mr. O'Leary was Vice President of Operations of Cablevision Indtries, where he ran $125 million of biness until it was sold to Time Warner. Mr. O'Leary started his professional career as a senior accountant with Peat Marwick and Mitchell (KPMG). Mr. O'Leary holds a B.B.A. degree in Accounting with honors from Siena College.
Michael Dent

迈克尔·登特于1996年创立了那不勒斯妇女中心,从组建到2016年2月,他一直担任该中心的首席执行官。他还自2014年1月起担任InLight Capital Partners LLC的联合创始人和董事总经理,负责其医疗保健、信息技术和生命科学投资。自90年代中期以来,他在biness开发、运营、企业发展以及医疗保健和技术指数领域的战略等领域担任关键领导职务。在创立InLight Capital Partners之前,Dent博士是NeoGenomics Laboratories(纳斯达克:NEO)的创始人、董事长兼首席执行官,并于1998年至2015年7月担任该公司的董事会成员。作为一名退休医师,登特博士具有独特的资格,能够理解医疗保健和新兴技术方面的挑战和机遇。登特博士在戴维森学院获得学士学位,主修生物学和医学预科,随后在南卡罗来纳州查尔斯顿的南卡罗来纳大学获得医学学位。Dent博士还参加了佛罗里达州墨西哥湾沿岸大学的Biness Executive Education Program。Dent博士与MedOfficeDirect(创始人)有董事会关联。


Michael Dent founded the Naples Women's Center in 1996 where he served as its principal executive from formation through February 2016. He is also Co Founder and Managing Director of InLight Capital Partners LLC since January 2014 and is responsible for its healthcare, information technology and life science investments. He has held key leadership positions in biness development, operations, corporate development, and strategy in the healthcare and technology indtries since the mid 90s. Prior to founding InLight Capital Partners, Dr. Dent was Founder, Chairman and Chief Executive Officer of NeoGenomics Laboratories (Nasdaq: NEO) where he was on the board of directors from 1998 until July 2015. Dr. Dent received his bachelor's degree from Davidson College, where he majored in both Biology and Pre Med, and nt on to earn his medical degree from The University of South Carolina in Charleston, South Carolina. Dr. Dent also attended Florida Gulf Coast University's Biness Executive Education program. Dr. Dent holds a board affiliation with MedOfficeDirect (Founder).
迈克尔·登特于1996年创立了那不勒斯妇女中心,从组建到2016年2月,他一直担任该中心的首席执行官。他还自2014年1月起担任InLight Capital Partners LLC的联合创始人和董事总经理,负责其医疗保健、信息技术和生命科学投资。自90年代中期以来,他在biness开发、运营、企业发展以及医疗保健和技术指数领域的战略等领域担任关键领导职务。在创立InLight Capital Partners之前,Dent博士是NeoGenomics Laboratories(纳斯达克:NEO)的创始人、董事长兼首席执行官,并于1998年至2015年7月担任该公司的董事会成员。作为一名退休医师,登特博士具有独特的资格,能够理解医疗保健和新兴技术方面的挑战和机遇。登特博士在戴维森学院获得学士学位,主修生物学和医学预科,随后在南卡罗来纳州查尔斯顿的南卡罗来纳大学获得医学学位。Dent博士还参加了佛罗里达州墨西哥湾沿岸大学的Biness Executive Education Program。Dent博士与MedOfficeDirect(创始人)有董事会关联。
Michael Dent founded the Naples Women's Center in 1996 where he served as its principal executive from formation through February 2016. He is also Co Founder and Managing Director of InLight Capital Partners LLC since January 2014 and is responsible for its healthcare, information technology and life science investments. He has held key leadership positions in biness development, operations, corporate development, and strategy in the healthcare and technology indtries since the mid 90s. Prior to founding InLight Capital Partners, Dr. Dent was Founder, Chairman and Chief Executive Officer of NeoGenomics Laboratories (Nasdaq: NEO) where he was on the board of directors from 1998 until July 2015. Dr. Dent received his bachelor's degree from Davidson College, where he majored in both Biology and Pre Med, and nt on to earn his medical degree from The University of South Carolina in Charleston, South Carolina. Dr. Dent also attended Florida Gulf Coast University's Biness Executive Education program. Dr. Dent holds a board affiliation with MedOfficeDirect (Founder).
Jason Bishara

Jason Bishara曾担任NSI保险集团的执行副总裁兼金融业务负责人,该集团是美国五大私营保险机构之一,业务遍及美国所有50个州和100多个国家。在此职位上,他负责监督公司的财务部门业务,就管理责任产品向董事会、高管和机构投资者提供建议,包括董事和高级职员(D & O)、网络责任和就业实践责任(EPLI)的覆盖范围。Bishara先生在过渡到投资银行业务之前,最初是一名零售经纪人。作为1999年被Global Capital收购的一家投资银行公司的合伙人,Bishara先生在资本市场、公司融资和交易结构方面发展了强大的基础。2020年,他成立了Gwynella Capital,这是一家家族办公室,维持100 – 200万美元的战略微型股仓位,强调长期、非投机性投资。2014年,Jason创立了JAISIN Insurance,这是一家专门为小盘上市公司和风险支持企业提供风险缓解服务的精品机构。JAISIN的差异化方法将深刻的资本市场洞察力与量身定制的保险解决方案相结合。2023年,JAISIN Insurance被NSI Insurance Group收购,Bishara先生继续领导金融业务部门,并为成长阶段和上市公司的战略风险计划提供建议。


Jason Bishara has served as Executive Vice President and Financial Practice Leader at NSI Insurance Group, one of the five largest privately held insurance agencies in the United States, operating in all 50 states and more than 100 countries. In this capacity, he oversees the firm's Financial Lines Practice, advising boards, executives, and institutional investors on management liability products, including Directors & Officers (D&O), Cyber Liability, and Employment Practices Liability (EPLI) coverage. Mr. Bishara began as a retail broker before transitioning into investment banking. As a partner at an investment banking firm acquired by Global Capital in 1999, Mr. Bishara developed a strong foundation in capital markets, corporate finance, and deal structuring. In 2020, he established Gwynella Capital, a family office that maintains $1–2 million in strategic micro cap positions, emphasizing long term, non speculative investments. In 2014, Jason founded JAISIN Insurance, a boutique agency specializing in risk mitigation for small cap public companies and venture backed enterprises. JAISIN's differentiated approach combined deep capital markets insight with tailored insurance solutions. In 2023, JAISIN Insurance was acquired by NSI Insurance Group, where Mr. Bishara continues to lead the financial lines division and advise on strategic risk programs for growth stage and publicly traded companies.
Jason Bishara曾担任NSI保险集团的执行副总裁兼金融业务负责人,该集团是美国五大私营保险机构之一,业务遍及美国所有50个州和100多个国家。在此职位上,他负责监督公司的财务部门业务,就管理责任产品向董事会、高管和机构投资者提供建议,包括董事和高级职员(D & O)、网络责任和就业实践责任(EPLI)的覆盖范围。Bishara先生在过渡到投资银行业务之前,最初是一名零售经纪人。作为1999年被Global Capital收购的一家投资银行公司的合伙人,Bishara先生在资本市场、公司融资和交易结构方面发展了强大的基础。2020年,他成立了Gwynella Capital,这是一家家族办公室,维持100 – 200万美元的战略微型股仓位,强调长期、非投机性投资。2014年,Jason创立了JAISIN Insurance,这是一家专门为小盘上市公司和风险支持企业提供风险缓解服务的精品机构。JAISIN的差异化方法将深刻的资本市场洞察力与量身定制的保险解决方案相结合。2023年,JAISIN Insurance被NSI Insurance Group收购,Bishara先生继续领导金融业务部门,并为成长阶段和上市公司的战略风险计划提供建议。
Jason Bishara has served as Executive Vice President and Financial Practice Leader at NSI Insurance Group, one of the five largest privately held insurance agencies in the United States, operating in all 50 states and more than 100 countries. In this capacity, he oversees the firm's Financial Lines Practice, advising boards, executives, and institutional investors on management liability products, including Directors & Officers (D&O), Cyber Liability, and Employment Practices Liability (EPLI) coverage. Mr. Bishara began as a retail broker before transitioning into investment banking. As a partner at an investment banking firm acquired by Global Capital in 1999, Mr. Bishara developed a strong foundation in capital markets, corporate finance, and deal structuring. In 2020, he established Gwynella Capital, a family office that maintains $1–2 million in strategic micro cap positions, emphasizing long term, non speculative investments. In 2014, Jason founded JAISIN Insurance, a boutique agency specializing in risk mitigation for small cap public companies and venture backed enterprises. JAISIN's differentiated approach combined deep capital markets insight with tailored insurance solutions. In 2023, JAISIN Insurance was acquired by NSI Insurance Group, where Mr. Bishara continues to lead the financial lines division and advise on strategic risk programs for growth stage and publicly traded companies.

高管简历

中英对照 |  中文 |  英文
Duncan McGillivray

Duncan McGillivray曾担任HWH Community Development Group,LLC的总裁,该公司是一家获得美国财政部全国许可的社区发展实体,负责为资本项目提供融资,McGillivray先生在该公司为他的领导层强调的一系列建设项目提供资本项目融资指导,该项目旨在为迈阿密一个目标为4000万美元的新建筑项目提供资金。在此之前,从2018年6月至2022年8月,McGillivray先生担任美国卫生部(HRSA)的全国合作伙伴Capital Link的高级资本项目顾问。McGillivray先生为全A的社区卫生设施提供了战略规划、biness计划、财务预测和企业财务咨询,其中包括成功推动完成超过2亿美元的资助项目。在此职位上,McGillivray先生还担任美国HRSA贷款担保计划的国家binar负责人,为美国1,400家具有联邦资格的健康中心提供资本项目融资指导。McGillivray先生拥有35年的专业经验,包括曾在Union Bank、Morgan Guaranty TRT、Bank of America、Bank of California工作,并经营着一家名为Veritas Valuation Specialists,Inc.的家族拥有的BINY估价公司。


Duncan McGillivray served as the President of HWH Community Development Group, LLC, a U.S. Treasury nationally licensed community development entity for financing capital projects, where Mr. McGillivray provided capital project funding guidance to a wide range of construction projects highlighted by his leadership for a targeted $40M ground up new construction project in Miami. Prior to this, from June 2018 to August 2022, Mr. McGillivray served as a senior capital project consultant for Capital Link, a national cooperative partner of the U.S. Department of Health (HRSA). Mr. McGillivray provided strategic planning, biness plans, financial projections and corporate financial consulting for community health facilities across the A which included successfully facilitating the closing of over $200 million of funded projects. In this capacity, Mr. McGillivray also served as the U.S. HRSA's national binar leader for its Loan Guarantee Program to provide capital project financing guidance to the nation's 1,400 Federally Qualified Health Centers. Mr. McGillivray has 35 years of professional experience including work for Union Bank, Morgan Guaranty Trt, Bank of America, Bank of California and operating a family owned biness valuation company named Veritas Valuation Specialists, Inc.
Duncan McGillivray曾担任HWH Community Development Group,LLC的总裁,该公司是一家获得美国财政部全国许可的社区发展实体,负责为资本项目提供融资,McGillivray先生在该公司为他的领导层强调的一系列建设项目提供资本项目融资指导,该项目旨在为迈阿密一个目标为4000万美元的新建筑项目提供资金。在此之前,从2018年6月至2022年8月,McGillivray先生担任美国卫生部(HRSA)的全国合作伙伴Capital Link的高级资本项目顾问。McGillivray先生为全A的社区卫生设施提供了战略规划、biness计划、财务预测和企业财务咨询,其中包括成功推动完成超过2亿美元的资助项目。在此职位上,McGillivray先生还担任美国HRSA贷款担保计划的国家binar负责人,为美国1,400家具有联邦资格的健康中心提供资本项目融资指导。McGillivray先生拥有35年的专业经验,包括曾在Union Bank、Morgan Guaranty TRT、Bank of America、Bank of California工作,并经营着一家名为Veritas Valuation Specialists,Inc.的家族拥有的BINY估价公司。
Duncan McGillivray served as the President of HWH Community Development Group, LLC, a U.S. Treasury nationally licensed community development entity for financing capital projects, where Mr. McGillivray provided capital project funding guidance to a wide range of construction projects highlighted by his leadership for a targeted $40M ground up new construction project in Miami. Prior to this, from June 2018 to August 2022, Mr. McGillivray served as a senior capital project consultant for Capital Link, a national cooperative partner of the U.S. Department of Health (HRSA). Mr. McGillivray provided strategic planning, biness plans, financial projections and corporate financial consulting for community health facilities across the A which included successfully facilitating the closing of over $200 million of funded projects. In this capacity, Mr. McGillivray also served as the U.S. HRSA's national binar leader for its Loan Guarantee Program to provide capital project financing guidance to the nation's 1,400 Federally Qualified Health Centers. Mr. McGillivray has 35 years of professional experience including work for Union Bank, Morgan Guaranty Trt, Bank of America, Bank of California and operating a family owned biness valuation company named Veritas Valuation Specialists, Inc.
Michael Dent

迈克尔·登特于1996年创立了那不勒斯妇女中心,从组建到2016年2月,他一直担任该中心的首席执行官。他还自2014年1月起担任InLight Capital Partners LLC的联合创始人和董事总经理,负责其医疗保健、信息技术和生命科学投资。自90年代中期以来,他在biness开发、运营、企业发展以及医疗保健和技术指数领域的战略等领域担任关键领导职务。在创立InLight Capital Partners之前,Dent博士是NeoGenomics Laboratories(纳斯达克:NEO)的创始人、董事长兼首席执行官,并于1998年至2015年7月担任该公司的董事会成员。作为一名退休医师,登特博士具有独特的资格,能够理解医疗保健和新兴技术方面的挑战和机遇。登特博士在戴维森学院获得学士学位,主修生物学和医学预科,随后在南卡罗来纳州查尔斯顿的南卡罗来纳大学获得医学学位。Dent博士还参加了佛罗里达州墨西哥湾沿岸大学的Biness Executive Education Program。Dent博士与MedOfficeDirect(创始人)有董事会关联。


Michael Dent founded the Naples Women's Center in 1996 where he served as its principal executive from formation through February 2016. He is also Co Founder and Managing Director of InLight Capital Partners LLC since January 2014 and is responsible for its healthcare, information technology and life science investments. He has held key leadership positions in biness development, operations, corporate development, and strategy in the healthcare and technology indtries since the mid 90s. Prior to founding InLight Capital Partners, Dr. Dent was Founder, Chairman and Chief Executive Officer of NeoGenomics Laboratories (Nasdaq: NEO) where he was on the board of directors from 1998 until July 2015. Dr. Dent received his bachelor's degree from Davidson College, where he majored in both Biology and Pre Med, and nt on to earn his medical degree from The University of South Carolina in Charleston, South Carolina. Dr. Dent also attended Florida Gulf Coast University's Biness Executive Education program. Dr. Dent holds a board affiliation with MedOfficeDirect (Founder).
迈克尔·登特于1996年创立了那不勒斯妇女中心,从组建到2016年2月,他一直担任该中心的首席执行官。他还自2014年1月起担任InLight Capital Partners LLC的联合创始人和董事总经理,负责其医疗保健、信息技术和生命科学投资。自90年代中期以来,他在biness开发、运营、企业发展以及医疗保健和技术指数领域的战略等领域担任关键领导职务。在创立InLight Capital Partners之前,Dent博士是NeoGenomics Laboratories(纳斯达克:NEO)的创始人、董事长兼首席执行官,并于1998年至2015年7月担任该公司的董事会成员。作为一名退休医师,登特博士具有独特的资格,能够理解医疗保健和新兴技术方面的挑战和机遇。登特博士在戴维森学院获得学士学位,主修生物学和医学预科,随后在南卡罗来纳州查尔斯顿的南卡罗来纳大学获得医学学位。Dent博士还参加了佛罗里达州墨西哥湾沿岸大学的Biness Executive Education Program。Dent博士与MedOfficeDirect(创始人)有董事会关联。
Michael Dent founded the Naples Women's Center in 1996 where he served as its principal executive from formation through February 2016. He is also Co Founder and Managing Director of InLight Capital Partners LLC since January 2014 and is responsible for its healthcare, information technology and life science investments. He has held key leadership positions in biness development, operations, corporate development, and strategy in the healthcare and technology indtries since the mid 90s. Prior to founding InLight Capital Partners, Dr. Dent was Founder, Chairman and Chief Executive Officer of NeoGenomics Laboratories (Nasdaq: NEO) where he was on the board of directors from 1998 until July 2015. Dr. Dent received his bachelor's degree from Davidson College, where he majored in both Biology and Pre Med, and nt on to earn his medical degree from The University of South Carolina in Charleston, South Carolina. Dr. Dent also attended Florida Gulf Coast University's Biness Executive Education program. Dr. Dent holds a board affiliation with MedOfficeDirect (Founder).
Jeremy Daniel

Jeremy Daniel自2019年起担任上市生物技术公司Innoveren Scientific的首席财务官。在加入Innoveren之前,Daniel先生曾在Regenerative Medicine Solutions(2013年第19届)和美国睡眠呼吸暂停治疗中心担任首席财务官职务,并在Omnicare担任财务总监(2012年第14届)。Daniel先生拥有Xavier大学Biness Administration的Biness Administration硕士学位和辛辛那提大学Biness Administration和会计学学士学位。Daniel先生也是一名注册会计师。


Jeremy Daniel has served as Chief Financial Officer for Innoveren Scientific, a publicly traded biotech firm, since 2019. Before his time at Innoveren, Mr. Daniel held the positions of Chief Financial Officer at Regenerative Medicine Solutions (2013 19) and at Sleep Apnea Treatment Centers of America, and Controller for Omnicare (2012 14). Mr. Daniel holds a Master of Biness Administration in Biness Administration from Xavier University and a Bachelor of Biness Administration and Accounting from The University of Cincinnati. Mr. Daniel is also a Certified Public Accountant.
Jeremy Daniel自2019年起担任上市生物技术公司Innoveren Scientific的首席财务官。在加入Innoveren之前,Daniel先生曾在Regenerative Medicine Solutions(2013年第19届)和美国睡眠呼吸暂停治疗中心担任首席财务官职务,并在Omnicare担任财务总监(2012年第14届)。Daniel先生拥有Xavier大学Biness Administration的Biness Administration硕士学位和辛辛那提大学Biness Administration和会计学学士学位。Daniel先生也是一名注册会计师。
Jeremy Daniel has served as Chief Financial Officer for Innoveren Scientific, a publicly traded biotech firm, since 2019. Before his time at Innoveren, Mr. Daniel held the positions of Chief Financial Officer at Regenerative Medicine Solutions (2013 19) and at Sleep Apnea Treatment Centers of America, and Controller for Omnicare (2012 14). Mr. Daniel holds a Master of Biness Administration in Biness Administration from Xavier University and a Bachelor of Biness Administration and Accounting from The University of Cincinnati. Mr. Daniel is also a Certified Public Accountant.